Navigation Links
Proteolix's Carfilzomib Receives Orphan Drug Designation for Treatment of Multiple Myeloma
Date:4/2/2008

SOUTH SAN FRANCISCO, Calif., April 2, 2008 /PRNewswire/ -- Proteolix, Inc., a clinical-stage company engaged in the development of novel pharmaceutical therapies for the treatment of cancer and immunological conditions, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to carfilzomib, a selective blocker of proteasome activity for the treatment of multiple myeloma. The orphan drug designation encompasses all subsets of multiple myeloma and Waldenstrom's macroglobulinemia.

"I am very pleased by our receipt of this designation for carfilzomib," said Susan Molineaux, Ph.D., the Company's President and CEO. "To date we have been encouraged by carfilzomib's early-stage clinical results in multiple myeloma, and we continue to believe it has the potential to offer cancer patients a new and effective treatment for their disease."

The Orphan Drug Act of 1983 allows the FDA to grant orphan drug status to novel drugs or biologics that treat a rare disease or condition affecting fewer than 200,000 patients in the U.S. According to the SEER Database of the National Cancer Institute (2004), the U.S. prevalence of multiple myeloma was 53,712 patients. The Orphan Drug Act provides the drug developer with several financial benefits and incentives related to the orphan drug, including tax credits for clinical research costs, ability to apply for annual grant funding, clinical research trial design assistance, waiver of Prescription Drug User Fee Act (PDUFA) filing fees, and a seven-year period of U.S. marketing exclusivity if the drug is the first of its type approved for the specified indication.

About Multiple Myeloma

Multiple myeloma is cancer of the plasma cell. It begins in the bone marrow, where blood cells are made. The plasma cell is a type of white blood cell that fights infections by making antibodies. Cancerous plasma cells, also called myeloma cells, divide and grow out of control, build
'/>"/>

SOURCE Proteolix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
2. Vermillion Meets Minimum Bid Price and Receives NASDAQ Staff Determination Letter for Minimum Market Capitalization
3. Pharmasset Receives $10 Million of Working Capital
4. Memory Pharmaceuticals Receives Audit Opinion Containing Going Concern Qualification
5. Actavis Receives Approval of Generic Wellbutrin SR(R) and Zyban(R) Tablets in the U.S.
6. Seneca Valley High School Student Receives Science Award From MedImmune
7. Cephalon Receives FDA Approval for TREANDA, a Novel Chemotherapy for Chronic Lymphocytic Leukemia
8. Medarex Receives Milestone Payment for Submission of Regulatory Application Requesting Approval of Golimumab (CNTO 148) in Europe for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
9. Oregon Health Care Quality Corporation Receives Important Designation from U.S. Department of Health and Human Services
10. AdvanDx Receives Frost & Sullivans Rapid In-Vitro Diagnostic Technology Innovation of the Year Award
11. Axial Biotech Meets Major Scientific Milestones; Receives $6 Million Tranche of Series B Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/3/2008)...Symbol: MS, EDMONTON, Oct. 3 /PRNewswire-FirstCal...loper in the treatment of multiple sclerosis (MS),...Monitoring Board (DSMB) for the,Company,s U.S. piv...8298),in patients with secondary progressive MS ha... the trial continue as per the protocol., This wa...
(Date:10/3/2008)...or Ap3ana, CTI,s ,personalized medicine, venture, ...erapeutics, Inc. (CTI),(Nasdaq: CTIC ) announced ...t recently President and COO of a Tyr Pharma and f...mics Institute of the Novartis Research,Foundation... Bresso, Italy,CTI Europe currently conducts the ...
(Date:10/2/2008)...2 /- Helix BioPharma,Corp. ... its private,placement announced on September 30, ...ss proceeds totaling CDN$11,424,000., Each unit c...mmon share,purchase warrant, with each whole commo...urchase, subject to adjustment, one common share a...
(Date:10/2/2008)...Provides Business Update to Investors, WILMINGTON...today at an,investor conference, DuPont Vice Presi...ny,s plans to bring its two advanced biofuels prog... technical progress toward the,commercialization o...stocks,economically into biofuels., "Biobutanol a...
Breaking Biology Technology:BioMS Medical's phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board 2Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe 2Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe 3Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe 4Helix Biopharma Closes $11.4 Million Private Placement 2DuPont Meeting Significant 2008 Milestones in Progressing Advanced Biofuels 2DuPont Meeting Significant 2008 Milestones in Progressing Advanced Biofuels 3
...in businesses will receive funding for technology ... of Commerce under the Technology Assistance Grant... to $15,000 to early-stage Wisconsin high-tech com.... The latest group of grant recipients are: Autom...ablate, LLC, Middleton; and Neurognostics, Inc. ,...
...t as much as buildings and there are many stakehol...the right people are involved and excited, said pr...oduced by WTN Media. , ,"User ownership is absolut...er Hospital . "If the users don,t know the applica...re going to have trouble when you go live." , ,Whe...
...re of managing liability in identity theft cases w...s Digital Healthcare Conference, and healthcare pr...d it would be. , ,Using a hypothetical case of ide... from Michael Best & Friedrich demonstrated how ...mselves in even when they take steps to prevent se...
...s a wireless protection system for boats and recre...ff-highway" mapping software for use by hikers, ca...ces a new type of milking system that is healthier..., ,If those ideas cry out "Wisconsin" to you, welc...ontest. , ,Twenty-seven finalists from 14 Wisconsi...
Other Biology Technology:Healthcare leaders tell how they rally stakeholders around IT 2Managing the nightmare of identity theft 2Managing the nightmare of identity theft 3Managing the nightmare of identity theft 4Business plan contest finalists reflect state's economic character 2Business plan contest finalists reflect state's economic character 3
(Date:10/5/2008)... the Journal of Cell Biology how the altered beh...in tumor cells., On 2D surfaces, cells may migrat...ns, which link the cell to the extracellular matri...ut exactly how has been unclear. Recent work has s...m movement, while an integrin called avb3 has been...
(Date:10/5/2008)...urrent financial climate has taught us anything, i...ked eventually ends in disaster. It turns out this...economics. Instead of cash, our body deals in ener... Unlike freewheeling financial markets, the lendi...to ensure that more isn,t lent than can be afforde...
(Date:10/3/2008)...ves to Focus on Top 100 Internet Retailers, BOISE...//www.kount.com ),a leading provider of fraud con...eterans Scott Lewer and Brad Canavan as National A... customers an unprecedented amount of,industry kno...nd online,payments., Scott Lewer is former genera...
(Date:10/3/2008)...thern pine beetle moves through the forest boring ...t both a helper and a competitor. The helper is a ...s food for its young. But also riding along is a t...ngus for feeding its own larvae. , Now the pictu... grown even more curious. Writing in the Oct. 3 is...
Breaking Biology News(10 mins):Food for thought -- regulating energy supply to the brain during fasting 2Food for thought -- regulating energy supply to the brain during fasting 3Kount Lands Veteran Fraud Experts From Retail Decisions and iovation 2Wielding microbe against microbe, beetle defends its food source 2Wielding microbe against microbe, beetle defends its food source 3RxElite Announces Acquisition of Assets of FineTech Laboratories 9426 1RxElite Announces Acquisition of Assets of FineTech Laboratories 9426 2RxElite Announces Acquisition of Assets of FineTech Laboratories 9426 3RxElite Announces Acquisition of Assets of FineTech Laboratories 9426 4CeraLyte ORS to Prevent Dehydration from Norovirus Outbreak 9421 1CeraLyte ORS to Prevent Dehydration from Norovirus Outbreak 9421 2Too Much Sugar Free Gum Linked to Severe Weight Loss 9418 1Too Much Sugar Free Gum Linked to Severe Weight Loss 9418 2Brain Circuits That Suppress Memory Found 9414 1Brain Circuits That Suppress Memory Found 9414 2
...ses western medicine & society,s embrace of me...edical Dean Edward Miller, and Georgetown Universi...h Western medicine,s increasing interest in medita...he Mind & Life Institute, in partnership with ...Johns Hopkins University School of Medicine will h...
... HapMap Project was initiated with the primary goa...g the genomic basis for human diseases. To coordi...ibing the HapMap, the journal Genome Research is... Variation," which is entirely devoted to studies ...logy and disease. , Predicting pregnancy success...
... HapMap Project was initiated with the primary goa...g the genomic basis for human diseases. To coordi...ibing the HapMap, the journal Genome Research is... Variation," which is entirely devoted to studies ...logy and disease. , Predicting pregnancy success...
... empower future drug designAs part of a $4.88 mill...F), molecular biologists from the University of Ro... create the first complete wiring diagram of a liv...tailed model, not only of the cell,s genes and the...m. When complete, the diagram has the potential to...
Other Biology News:Dalai Lama, top scientists to discuss science & clinical applications of meditation 2Dalai Lama, top scientists to discuss science & clinical applications of meditation 3Housecat-sized Siberian tiger cubs get collared 2Housecat-sized Siberian tiger cubs get collared 3Housecat-sized Siberian tiger cubs get collared 4Studies on human genome variation provide insight into disease 2Studies on human genome variation provide insight into disease 3Studies on human genome variation provide insight into disease 4New study to explore cellular circuitry 2New study to explore cellular circuitry 3
The iEMS Incubator/Shaker HT is designed for extended temperatures. Thus, the iEMS Incubator/Shaker HT is ideal for applications such as DNA hybridization and primer extension assays. iEMS Incubator/
The iEMS Incubator/Shaker is a high performance microplate incubator and orbital shaker. Its superior temperature control and efficient orbital shaking reduce incubation times. -
The iEMS Incubator/Shaker is a high performance microplate incubator and orbital shaker. Its superior temperature control and efficient orbital shaking reduce incubation times. It can incubate up to
...i-Reverse Cap Analog (ARCA) is a modified cap anal...aced with OCH3. Because of this substitution, the ...h the remaining hydroxyl group thus forcing ARCA i...lt, unlike transcripts synthesized with convention...
Biology Products: